Interferon-γ deficiency reduces neointimal formation in a model of endoluminal endothelial injury combined with atherogenic diet

Tavakoli,Nasim  Nik; Harris,Angie  K.; Sullivan,David  R.; Hambly,Brett  D.; Bao,Shisan

doi:10.3892/ijmm.2012.1034

Interferon-γ deficiency reduces neointimal formation in a model of endoluminal endothelial injury combined with atherogenic diet

Authors:
- Nasim Nik Tavakoli
- Angie K. Harris
- David R. Sullivan
- Brett D. Hambly
- Shisan Bao
View Affiliations

Affiliations: Discipline of Pathology, School of Medical Sciences and Bosch Institute, The University of Sydney, Sydney, New South Wales, Australia, Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
Published online on: June 15, 2012 https://doi.org/10.3892/ijmm.2012.1034
Pages: 545-552

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Interferon (IFN)-γ has been implicated in restenosis, however its precise role in the pathophysiology of neointimal formation following angioplasty is unclear, as it has been shown to both promote and inhibit neointimal formation. Dietary-induced hypercholesterolemia enhances injury-mediated neointimal formation, associated with increased systemic inflammation and serum IFN-γ. This study examined the effect of IFN-γ gene deficiency (-/-) on neointimal formation in a mouse model of endothelial injury combined with an atherogenic diet. Neointimal formation was induced via endoluminal endothelial injury of the common iliac arteries of IFN-γ-/- and wild-type (WT) C57Bl/6 mice. Histopathological analysis of the arteries was performed at 3 and 6 weeks post-surgery. IFN-γ-/- mice demonstrated a significant reduction in neointimal formation at the 3‑week time point, compared to their WT counterpart. No significant differences in plasma lipid profile and the extent of re-endothelialization were detected between IFN-γ-/- and WT mice, suggesting that the effect of IFN-γ on neointimal formation is due to injury-mediated vessel neointimal responses. In support of the histopathological findings, immunohistochemical analysis revealed a significant reduction in vessel infiltrating macrophages, and neointimal PDGF-B expression, vascular smooth muscle cell composition and cellular proliferation in the IFN-γ-/- mice, in comparison to their corresponding WT group at the 3-week time point. In conclusion, the IFN‑γ‑mediated pathway plays an important role in inflammatory responses and proliferative effects following injury, suggesting that modulation of the IFN-γ pathway would be beneficial in controlling neointimal formation and restenosis.

View Figures

View References

1.	JJ LiSP NieCY ZhangZ GaoX ZhengYL GuoIs inflammation a contributor for coronary stent restenosis?Med Hypotheses68945951200710.1016/j.mehy.2006.05.06917045418
2.	MR BennettIn-stent stenosis: pathology and implications for the development of drug eluting stentsHeart89218224200310.1136/heart.89.2.21812527687
3.	RS SchwartzDR Holmes JrEJ TopolThe restenosis paradigm revisited: an alternative proposal for cellular mechanismsJ Am Coll Cardiol2012841293199210.1016/0735-1097(92)90389-51401633
4.	EJ HarveyDP RamjiInterferon-gamma and atherosclerosis: pro- or anti-atherogenic?Cardiovasc Res671120200510.1016/j.cardiores.2005.04.01915907820
5.	K SchroderPJ HertzogT RavasiDA HumeInterferon-gamma: an overview of signals, mechanisms and functionsJ Leukoc Biol75163189200410.1189/jlb.060325214525967
6.	ML LeonSH ZuckermanGamma interferon: a central mediator in atherosclerosisInflamm Res54395411200510.1007/s00011-005-1377-216283107
7.	G TellidesDA TerebNC Kirkiles-SmithInterferon-gamma elicits arteriosclerosis in the absence of leukocytesNature403207211200010.1038/3500322110646607
8.	Y NunokawaS TanakaInterferon-gamma inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generationBiochem Biophys Res Commun188409415199210.1016/0006-291X(92)92400-R1384487
9.	GK HanssonL JonassonJ HolmMM ClowesAW ClowesGamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitroCirc Res63712719198810.1161/01.RES.63.4.7123139321
10.	H MuhlJ PfeilschifterAnti-inflammatory properties of pro-inflammatory interferon-gammaInt Immunopharmacol312471255200310.1016/S1567-5769(03)00131-012890422
11.	K KusabaH KaiM KogaInhibition of intrinsic interferon-gamma function prevents neointima formation after balloon injuryHypertension49909915200710.1161/01.HYP.0000259668.37901.8c17309951
12.	M ParoliP MarianiD AccapezzatoModulation of tachykinin and cytokine release in patients with coronary disease undergoing percutaneous revascularizationClin Immunol1127884200410.1016/j.clim.2004.03.02115207784
13.	D ZohlnhoferT RichterF NeumannTranscriptome analysis reveals a role of interferon-gamma in human neointima formationMol Cell710591069200110.1016/S1097-2765(01)00239-811389852
14.	GK HanssonJ HolmInterferon-gamma inhibits arterial stenosis after injuryCirculation8412661272199110.1161/01.CIR.84.3.12661909221
15.	M BusnelliA FroioML BacciPathogenetic role of hypercholesterolemia in a novel preclinical model of vascular injury in pigsAtherosclerosis207384390200910.1016/j.atherosclerosis.2009.05.02219540496
16.	DK DaltonS Pitts-MeekS KeshavIS FigariA BradleyTA StewartMultiple defects of immune cell function in mice with disrupted interferon-gamma genesScience25917391742199310.1126/science.84563008456300
17.	AK HarrisJ ShenJ RadfordS BaoBD HamblyGM-CSF deficiency delays neointima formation in a normolipidemic mouse model of endoluminal endothelial damageImmunol Cell Biol87122130200910.1038/icb.2008.7318839015
18.	J ShenM WhiteAJ HusbandBD HamblyS BaoPhytoestrogen derivatives differentially inhibit arterial neointimal proliferation in a mouse modelEur J Pharmacol548123128200610.1016/j.ejphar.2006.07.05016950243
19.	S BaoKW BeagleyAM MurrayIntestinal IgA plasma cells of the B1 lineage are IL-5 dependentImmunology94181188199810.1046/j.1365-2567.1998.00512.x9741339
20.	J MiddletonL AmerichR GayonA comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146J Pathol206260268200510.1002/path.178815887283
21.	VJ PompiliD GordonH SanExpression and function of a recombinant PDGF B gene in porcine arteriesArterioscler Thromb Vasc Biol1522542264199510.1161/01.ATV.15.12.22547489251
22.	H MurayamaM TakahashiM TakamotoDeficiency of tumour necrosis factor-alpha and interferon-gamma in bone marrow cells synergistically inhibits neointimal formation following vascular injuryCardiovasc Res80175180200810.1093/cvr/cvn250
23.	M AoyagiM YamamotoH WakimotoH AzumaK HirakawaK YamamotoImmunohistochemical detection of Ki-67 in replicative smooth muscle cells of rabbit carotid arteries after balloon denudationStroke2623282332199510.1161/01.STR.26.12.2328
24.	P KurkiK OgataEM TanMonoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometryJ Immunol Methods1094959198810.1016/0022-1759(88)90441-3
25.	JM SongHS KimSJ ParkEffect of hypercholesterolemia on macrophage infiltration after balloon injury to rabbit iliac arteryJpn Circ J65117122200110.1253/jcj.65.11711216820
26.	MA BillettIS AdbeishSA AlrokayanAJ BennettCB MarenahDA WhiteIncreased expression of genes for platelet-derived growth factor in circulating mononuclear cells of hypercholesterolemic patientsArterioscler Thromb Vasc Biol16399406199610.1161/01.ATV.16.3.399
27.	GK HanssonInflammatory mechanisms in atherosclerosisJ Thromb Haemost7Suppl 1328331200910.1111/j.1538-7836.2009.03416.x
28.	SC WhitmanP RavisankarA DaughertyIFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E^−/− miceJ Interferon Cytokine Res22661670200210.1089/1079990026010014112162876
29.	L VergnesJ PhanM StraussS TafuriK ReueCholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expressionJ Biol Chem2784277442784200310.1074/jbc.M30602220012923166
30.	C BuonoCE ComeG StavrakisGF MaguirePW ConnellyAH LichtmanInfluence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouseArterioscler Thromb Vasc Biol23454460200310.1161/01.ATV.0000059419.11002.6E12615659
31.	N KipshidzeG DangasM TsapenkoRole of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventionsJ Am Coll Cardiol447337392004
32.	PR MorenoVH BernardiJ Lopez-CuellarMacrophage infiltration predicts restenosis after coronary intervention in patients with unstable anginaCirculation9430983102199610.1161/01.CIR.94.12.3098
33.	HD DanenbergI FishbeinJ GaoMacrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbitsCirculation106599605200210.1161/01.CIR.0000023532.98469.48
34.	P LibbyD SchwartzE BrogiH TanakaSK ClintonA cascade model for restenosis. A special case of atherosclerosis progressionCirculation86111471115219921424051
35.	K MaiellaroWR TaylorThe role of the adventitia in vascular inflammationCardiovasc Res75640648200710.1016/j.cardiores.2007.06.02317662969
36.	CH HeldinB WestermarkMechanism of action and in vivo role of platelet-derived growth factorPhysiol Rev7912831316199910508235
37.	Z ZhouMA LauerK WangEffect of anti-tumor necrosis factor-alpha polyclonal antibody on restenosis after balloon angioplasty in a rabbit atherosclerotic modelAtherosclerosis161153159200210.1016/S0021-9150(01)00640-2